Status:
UNKNOWN
Feasibility and Preliminary Effectiveness of a Shared Decision-making Process
Lead Sponsor:
Hospital Vall d'Hebron
Conditions:
Clinical Decision Making
Patient-Centered Care
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Shared decision-making is a process where health professionals and patients work together through conversation and using tools to make the best possible decision for the person. Patient de...
Detailed Description
Background: Shared decision-making is a process where health professionals and patients work together through conversation and using tools to make the best possible decision for the person. Patient de...
Eligibility Criteria
Inclusion
- Inclusion Criteria Obesity:
- Adult patients, between 18 and 60 years old, Spanish or Catalan speakers, who have scheduled a visit to the obesity clinic.
- BMI≥40Kg/m2 or ≥35kg/m2 with major associated comorbidities, likely to improve after weight loss
- Presence of morbid obesity established for at least five years
- Absence of endocrine disorders that cause obesity
- Favorable psychiatric-psychological evaluation
- Informed consent to participate in the study after having received all the necessary information (oral and written)
- Exclusion Criteria Obesity:
- Patient with cognitive impairment that does not allow for a shared decision-making process.
- Unstable organic disease limiting the probability of success and benefit of participation in the obesity unit program.
- Patients previously operated on bariatric surgery
- Clinical contraindications included in the general criteria of the Bariatric Surgery Protocol of the Hospital Universitari Vall d'Hebron
- Clinical contraindications for pharmacological treatment according to technical date of GLP-1 analogues (Trulicity, Ozempic, Victoza, Saxenda)
- Inclusion Criteria ACKD:
- Adult patients aged 18 or over who speak Spanish or Catalan who have a scheduled visit to the ACKD clinic.
- Advanced chronic kidney disease (GFR ≤20ml/min) that requires assessment of the start of renal replacement therapy through any dialysis, transplant or conservative treatment.
- Informed consent to participate in the study after having received all the necessary information (oral and written)
- Exclusion Criteria ACKD:
- Having previously performed any modality of renal replacement therapy.
- Patient with cognitive impairment that does not allow for a shared decision-making process.
Exclusion
Key Trial Info
Start Date :
May 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 23 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05424809
Start Date
May 20 2022
End Date
December 23 2022
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Vall d'Hebron
Barcelona, Spain, 08023